Identifying a Six-Gene Signature Predicting Response to TACE in Hepatocellular Carcinoma by Bioinformatics Analysis

Table 1

DEGs between HCC samples from TACE responders () and nonresponders () by analyzing the GSE104580 dataset.

	Upregulated DEG ()	Downregulated DEG ()
DEGs (158)	AQP1; AK021804; C7; IFIT1; RTP4; IFI27; SPARCL1; FAS; CES2; AKR7A3; ADH1C; UGT2B15; CLDN2; CYP1A2; CD5L; CYP3A4; CYP1A1; THRSP; C3P1; RDH16; LINC00844; HSD11B1; ETNPPL; NUDT6; LDHD; SLCO1B1; CFHR4; HPR; FETUB; RBP5; ADHFE1; GLYAT; GYS2; C6; CYP8B1; HAO2; FGGY; ANXA10; SRD5A2; CYP2A6; CYP2A7; CYP2C9; FLJ22763; OGDHL; GNMT; PON3; LINC01018; ACSM2A; ACSM2B; CYP4F2; DAO; UPB1; SLC6A1; APOA5; EPHX2; AGXT; HPX; HRG; PIPOX; SERPINC1; AFM; HSD17B6; SLC22A1; SLC10A1; C4BPA; F9; CYP7A1; BHMT; AASS; NR1I3; IGFBP2; CYP4A11; SPP2; CCL16; RTP3; AQP9; HGFAC; PGLYRP2; ZG16; PCK1; HPD; ADH4; ANGPTL3; ACOT12; LECT2; ADH6; ADH1A; ADH1B; ABCC6P1; KLHDC9; CYP2C18; IL32	FMO1; RP11−274H2.5; GAL3ST1; VNN2; CA9; NDRG1; SLC6A8; KISS1R; ENO2; HILPDA; SPAG4; SULT1C2; ZIC2; ASRGL1; CLGN; MAP7D2; CTHRC1; EPCAM; FOXQ1; DKK1; MMP9; COLEC12; SPINK1; CCL20; SPP1; CXCL8; HK2; MMP12; DUSP9; TRIM71; AFP; TET1; ENPP3; RFX6; KANK4; RBP2; MEP1A; XK; SLAIN1; IL13RA2; FKBP1B; STEAP2; STEAP1; FDCSP; NTS; QPCT; S100A9; S100A8; ARG2; LIN28B; POPDC3; TSPAN13; AGR2; MMP1; GCNT3; ENPP5; PKIB; CD24; MAPK13; IGF2BP3; PLBD1; C15orf48; HCAR3; BCL2A1; CA12; TREM1